RankingsPricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Cash and cash equivalents

AFC-HD AMS Life Science Co.,Ltd.JP:2927

Market cap
¥12.4B
P/E ratio
8.3x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Aug 31, 202511,303-7.14%
Aug 31, 202412,173+8.86%
Aug 31, 202311,182+7.75%
Aug 31, 202210,378+12.53%
Aug 31, 20219,222+95.15%
Aug 31, 20204,726+6.50%
Aug 31, 20194,437+8.77%
Aug 31, 20184,080+20.28%
Aug 31, 20173,392-8.89%
Aug 31, 20163,723-7.83%
Aug 31, 20154,039-1.95%
Aug 31, 20144,119

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)